Advertisement

Picture EBD Group BioPharm America 2017 BPA Boston MA September 600x60px
Document › Details

Agilent Technologies Inc.. (11/11/14). "Press Release: Agilent Technologies Introduces New Column Innovations for Biotherapeutics Development. Reversed-phase Columns Optimized to Separate Monoclonal Antibodies". Santa Clara, CA.

Organisation Organisation Weber Shandwick, Chicago Office
  Group Interpublic Group (IPG) (Group)
Products Product AdvanceBio RP-mAb column
  Product 2 MAb
Person Person Jones, Anne (Agilent 201207 General Manager at Chemistries Division)
     


Agilent Technologies Inc. (NYSE: A) today introduced the AdvanceBio RP-mAb, a reversed-phase column optimized to separate monoclonal antibodies. The AdvanceBio RP-mAb – the latest in a series of products in the AdvanceBio family-is part of Agilent's extensive R&D effort to support biological research and drug development by increasing the accuracy and productivity of biocolumns technology.

Monoclonal antibodies, or mAbs, are the primary proteins researchers study to develop biotherapeutics, biosimilars and biobetters.

"The Agilent AdvanceBio RP-mAb is the only reversed-phase column optimized specifically for mAbs," said Anne Jones, Agilent's vice president of Chemistries. "Its 450Å pore size is optimal for obtaining higher resolution-a vital factor for researchers, as mAbs are notoriously difficult to analyze."

Like all Agilent's industry-leading AdvanceBio products, the new column is designed and manufactured solely by Agilent for premium, end-to-end quality control.

AdvanceBio RP-mAb columns leverage Agilent's Poroshell technology for fast, high-resolution analysis of intact mAbs. The column is 3.5 µm, 450Å superficially porous, and stable to 600 bar. Agilent also offers three chemistries-C8, C4 and unique diphenyl-providing researchers with options for refining their separations.


About Agilent Technologies

Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics and applied chemical markets, is the premier laboratory partner for a better world. Agilent works with customers in more than 100 countries, providing instruments, software, services and consumables for the entire laboratory workflow. Agilent generated revenues of $3.9 billion in fiscal 2013. The company employs about 11,000 people worldwide. Information about Agilent is available at www.agilent.com.

# # #

Contact:

Jennifer Mann
+1 303 357 2391
jmann@webershandwick.com

   
Record changed: 2016-03-19

Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px

More documents for Agilent (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA September 120x180px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA September 120x180px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px